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doi:10.1016/j.joca.2010.05.010In the current issue,Mazzuca et al.1 report, froma trial of the effect
of doxycycline onmedial joint spacenarrowing, the results of post hoc
treatment group comparisons in subgroups of varus and non-varus
osteoarthritic knees. These analyses were undertaken to ascertain
whether varus malalignment decreased the structure-modifying
effect of doxycycline. The sample included 379 obese, 45–64-year
old women with unilateral knee osteoarthritis (OA). Mazzuca et al.
found that, in the non-varus osteoarthritic knees, 16-month joint
space narrowing was 44% slower and 30-month narrowing was 39%
slower in thedoxycyclinegroupthan intheplacebogroup. Incontrast,
in the varus osteoarthritic knees, this differencewas blunted; the rate
of joint space narrowing was unaffected by doxycycline.
The study, a randomized, placebo-controlled trial of doxycy-
cline, has a number of strengths in its design and methodology as
well as in its performance, e.g., state-of-the-art methods to acquire
knee radiographs optimizing conditions for measurement of
medial tibiofemoral joint space and outstanding participant reten-
tion especially given the long duration of the study. While align-
ment was measured from the knee ﬁlm, great care was taken in
the measurement protocol and in transforming the measurement
to an estimate of the mechanical axis angle.
As the authors acknowledge, there are some limitations as well.
For compelling reasons, the trial was performed in obese women,
but this may limit generalizability of these ﬁndings. Varus align-
ment was less frequent than might be expected, which the authors
attribute to the exclusion of Kellgren and Lawrence (K/L) grade 4
knees and to the method of measuring alignment from relatively
short visualized segments of the tibial and femoral shafts on the
knee radiograph. The frequency of varus was less than the 27%
frequency in the Rotterdam study in which K/L grade 3 and 4 knees
had been excluded and which had also relied on knee X-rays with
offset correction to estimate full-limb alignment2. Alignment inﬂu-
ences tibiofemoral load distribution, but alignment as it is typically
measured is a static parameter. Varus knees had more severe oste-
oarthritic disease at baseline and, on this basis, may have been
more likely to experience OA progression than the non-varus
knees.Research Society International. PuThis study illustrates some caveats inherent to radiographic
joint space measurement as a measure of outcome in studies of
knee OA. The magnitude of change in joint space width was small,
even by 30 months, and it is difﬁcult to know whether this incre-
ment of change is important. And, joint space loss in the osteoar-
thritic knee may reﬂect meniscal tissue damage or extrusion,
conditions which may be exacerbated by malalignment.
The outcome measure of medial joint space narrowing was well
chosen for the primary goals of the trial but creates some chal-
lenges for these post hoc analyses. The non-varus group included
valgus knees. Valgus osteoarthritic knees may include knees with
medial tibiofemoral OA but are more likely (than varus or neutral
knees) to have lateral OA. The measurement of medial joint space
in a knee with lateral OA is difﬁcult to interpret. Knees with lateral
OA may experience some medial narrowing (presumably less than
lateral narrowing), no change in medial joint space width, or
medial pseudowidening that is reciprocal to lateral narrowing.
The authors acknowledge that valgus knees may not have been
well suited to demonstrate a disease-modifying effect in the medial
compartment, and provide evidence that, on average, the valgus
knees experienced some medial narrowing over time. The hetero-
geneity of outcomes in themedial compartment of the valgus knees
with lateral OA makes this aspect of the study difﬁcult to interpret.
Radiographic methods are inherently limited in their ability to
assess disease status or progression in the uninvolved or less
involved tibiofemoral compartment. By providing direct visualiza-
tion of medial and lateral articular cartilage and menisci, MRI
bypasses these limitations of radiography.
The study by Mazzuca et al. is important – it illustrates the type
of approach that will be essential towards an ultimate goal of
solving a signiﬁcant problem. The problem is that certain mechan-
ical environments may reduce the effectiveness of pharmacologic
therapy3,4.
Varus–valgus alignment is one important determinant of this
mechanical environment. In a varus aligned knee, the load-bearing
axis passes medial to the knee, creating a moment arm that
increases forces across the medial tibiofemoral compartment; inblished by Elsevier Ltd. All rights reserved.
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lateral to the knee, and the moment arm created increases forces
across the lateral compartment. Due to a stance phase knee adduc-
tion moment, even during normal gait in healthy knees, 70% of
forces pass through the medial compartment. Varus alignment is
a key determinant of the magnitude of this adduction moment.
Varus alignment (in several studies) and the adduction moment5
have each been associated with a greater risk of subsequent medial
OA progression. An increase in the adductionmomentmay lie in the
causal pathway between varus alignment and disease progression.
Malalignment is important for reasons in addition to these direct
effects at the knee. First, malalignment stresses not only articular
hyaline cartilage but also other knee joint tissues, including the
menisci, subchondral bone, and ligaments, which may contribute
to the development andprogressionofOA. Second, there is evidence
that malalignment alters the effect of other risk factors. Third,
whether or not malalignment precedes OA development, it may
participate in a vicious cycle with worsening of knee OA. From
a biomechanical perspective, it is likely that the relationship
between malalignment and knee OA worsening is bidirectional. It
is difﬁcult to imagine how pharmacologic therapy could alter the
natural history of an osteoarthritic knee in this vicious cycle, given
the magnitude of the mechanical forces at work and the frequency
with which they are transmitted during weight-bearing activity.
Felson and Kim attributed the failure to develop chondroprotec-
tive pharmacologic treatment to the assumption that pharmaco-
logic therapy would work regardless of the mechanical
environment3. However, this thoughtful conceptualization of the
problem in the literature does not seem to have spurred speciﬁc
investigation within trials. In fairness, how to handle elements of
the mechanical environment is not a straightforward issue. Logical
alternatives include stratiﬁed analyses (such as those performed by
Mazzuca et al.), excluding knees that are malaligned, or providing
a co-intervention that addresses the malalignment-associated
load imbalance3. Of these, the second and third options are less
desirable at present. In terms of the second option, depending
upon how malalignment is deﬁned, a substantial number of knees
could be excluded. Even mild deviation from neutral alignment
may have an impact – this is not known but stratiﬁed analyses
would help to elucidate this. In terms of the third option, while
several non-invasive interventions are being developed or are
under study, there is insufﬁcient data upon which to base a choice.
There are also limiting issues of tolerability (e.g., unloading braces)
and uncertainty regarding optimal design of wedge insoles. At this
point in time, the third option does not seem practical, although it
is an excellent goal for the future.
The paper by Mazzuca et al. is an important step and should
stimulate more consistent consideration of the mechanical envi-
ronment within future trials. It is crucial to continue down this
path; some drugs may have a substantially better effect in knees
that are more neutrally aligned. There are at least four categories
of studies that are needed to begin to address the problem that
pharmacologic therapy may have no or a reduced chance of being
effective unless key elements of the mechanical environment are
addressed.
First, trial design needs to support analyses within key mechan-
ical factor (such as alignment) strata; this strategy will be more
informative than only testing knees with an optimal mechanical
environment. With careful attention to methodology (as in the
study by Mazzuca et al.), knee X-rays can provide a reasonable esti-
mate of the mechanical axis angle. Given this, investigators ofcompleted trials should consider repeating analyses within strata,
especially since there may be no future trials for certain drugs.
Although these investigators will face the same inherent limita-
tions of radiography as described above, the existing images and
data are a rich resource to begin to tackle this complex issue.
Second, studies need to identify other important mechanical
factors or determinants of the mechanical environment, perhaps
even under dynamic conditions. Ultimately, inexpensive and prac-
tical methods to measure such factors will have to be developed.
Third, efforts should continue to develop MRI-based outcome
measures that can function as the primary outcome in a trial. There
are inherent limitations to radiography that acquisition and reading
protocols cannotovercome. It isnot possibleusingX-ray todetermine
at early disease stages which tibiofemoral compartment will be
predominantly involved. It is unclear how to assess progression in
the compartment not predominantly involved. It is not clear how
much radiographic joint space narrowing represents meniscal
damage or extrusion; the meniscal contribution may differ between
knees. Ourheavy reliance on radiographicmedial joint space narrow-
ing makes it challenging to examine effect modiﬁcation by a factor
like alignment that has effects speciﬁc to each tibiofemoral compart-
ment. MRI, in its potential to measure cartilage loss and in its
potential tomeasure cartilage dysfunction that precedes loss is vastly
superior.
Fourth, non-invasive interventions to optimize key elements of
the mechanical environment should be developed further and
tested towards an ultimate goal of using them together with phar-
macologic therapy in clinical trials.
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